Sarah Albala is a Policy Fellow in Public Value and Policy Evaluation at the UCL Institute for Innovation and Public Purpose (IIPP).
Her main project, which is funded by the Department for International Development (DFID), seeks to propose a re-oriented framework that will best capture and make transparent the overall social and economic value that is produced when the public sector invests in assistive health technologies. As part of this grant, she has also produced research for the WHO Global Research, Innovation, and Education in Assistive Technology (GREAT) Summit. Her interest in the area of dynamic policy evaluation can also be noted by her contributions to a policy report issued by BEIS, Department for Business, Energy & Industrial Strategy, which examined state of the art practices in policy evaluation methodologies, as well as her work with the BBC on creating an evaluation framework to best capture dynamic public value and market shaping effects.
She is joining IIPP after working within the Health Policy Department at the London School of Economics and Political Science where she took part in a variety of health economic and health policy research projects. Her outputs at the LSE included the creation of a policy framework to evaluate anti-microbial resistance governance throughout the European Union and a Lancet series paper on how to best digitise the NHS. Sarah has conducted research on health systems around the world, including Tanzania, Ghana, Moldova and Grenada, where she collaborated with international organisations, government ministries, and community participants.
Selected publications
- Academic working papers
Albala, S., et al. (2019). Capturing and Creating Value in the Assistive Technologies Landscape through a Mission-Oriented Approach: A New Research and Policy Agenda. AT2030 Working Paper Series.